NCT01324622

Brief Summary

The objective of this study is to compare the clinical and radiographic outcomes of multi-level laminectomy to multi-level laminoplasty in the treatment of patients with cervical myelopathy or myeloradiculopathy. The hypothesis for the study is that the laminoplasty group is not inferior to the laminectomy group.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2006

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 23, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 29, 2011

Completed
6.1 years until next milestone

Results Posted

Study results publicly available

April 17, 2017

Completed
Last Updated

December 7, 2017

Status Verified

October 1, 2017

Enrollment Period

4.8 years

First QC Date

March 23, 2011

Results QC Date

April 10, 2015

Last Update Submit

November 3, 2017

Conditions

Keywords

Spinal Cord DiseasesMyelopathyMyeloradiculopathyLaminectomyLaminoplasty

Outcome Measures

Primary Outcomes (3)

  • Imrovement in Modified Japanese Orthopaedic Assessment (mJOA) Recovery Rate

    Number of participants who have mJOA Recovery Rate ≥0%. mJOA Recovery Rate is defined as: mJOA Recovery Rate = ((PostOp Score-PreOp Score)/(17 - Pre-Op Score))\*100

    12 months

  • Sagittal Angle Success

    Success defined as ≤ +15º (kyphosis) as indicated by a neutral lateral radiograph

    12 months

  • Incidence of Surgical Interventions

    Success defined as a lack of revision, removal or addition of supplemental fixation.

    up to 24 months

Secondary Outcomes (9)

  • Pain Scores on the Visual Analog Scale

    Up to 24 months

  • Functional Improvement Using the Neck Disability Index (NDI)

    up to 24 months

  • Quality of Life Improvement Using the SF-12 Scale

    up to 24 months

  • Motor Deficit

    up to 24 months

  • Reflex Evaluation

    up to 24 months

  • +4 more secondary outcomes

Study Arms (2)

Laminectomy

ACTIVE COMPARATOR

Control

Procedure: laminectomy

Laminoplasty

ACTIVE COMPARATOR

Treatment group

Device: Laminoplasty

Interventions

Utilizing the ARCH Fixation System (Study device)

Also known as: ARCH Fixation System
Laminoplasty
laminectomyPROCEDURE

standard procedure

Laminectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient must be at least 18 years of age and have no evidence of developmental anomaly of the cranial cervical junction and/or cervical spine
  • The patient has the diagnosis of cervical myelopathy
  • The myelopathy or myeloradiculopathy requires a posterior cervical decompression of the spinal canal involving two or more contiguous intervertebral levels including and between C3 and C7
  • The patient signs the study informed consent form.

You may not qualify if:

  • Primary symptoms and signs of cervical radiculopathy (only) without myelopathy.
  • Presence of primary focal anterior compression of the cervical spinal cord.
  • Ossification of the ligamentum flavum.
  • Previous surgery of the cervical spine.
  • Tumor, infection, or trauma of the cervical spine or cord.
  • Segmental instability - Pregnant or interested in becoming pregnant during the study follow-up period.
  • Known sensitivity to device materials.
  • Currently being treated or intends to be treated postoperatively with other devices for the same disorder (e.g., electrical stimulation devices, pain control devices, etc.).
  • Currently a participant in any other study related to the treatment of cervical spinal disorders.
  • Prisoner
  • Mentally incompetent, or unable to comply with the follow up regime

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Tower Orthopaedics

Beverly Hills, California, 90211, United States

Location

Yale University School of Medicine

New Haven, Connecticut, 06520, United States

Location

Research Medical Center

Kansas City, Missouri, 64132, United States

Location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Publications (1)

  • Edwards CC 2nd, Riew KD, Anderson PA, Hilibrand AS, Vaccaro AF. Cervical myelopathy. current diagnostic and treatment strategies. Spine J. 2003 Jan-Feb;3(1):68-81. doi: 10.1016/s1529-9430(02)00566-1.

    PMID: 14589250BACKGROUND

MeSH Terms

Conditions

Spinal Cord Diseases

Interventions

LaminoplastyLaminectomy

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Orthopedic ProceduresTherapeuticsNeurosurgical ProceduresSurgical Procedures, OperativeDecompression, Surgical

Limitations and Caveats

Slow enrollment and a low follow-up rate resulted in the early termination of the study and lead to a small numbers of subjects completing the study and limiting the data analysis.

Results Point of Contact

Title
Allyson Morris
Organization
DePuy Synthes

Study Officials

  • Carl Lauryssen, MD

    Tower Orthopaedics

    PRINCIPAL INVESTIGATOR
  • Daniel Riew, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2011

First Posted

March 29, 2011

Study Start

January 1, 2006

Primary Completion

November 1, 2010

Study Completion

November 1, 2010

Last Updated

December 7, 2017

Results First Posted

April 17, 2017

Record last verified: 2017-10

Locations